Skip to main content
Premium Trial:

Request an Annual Quote

Gene Security Network Raises $6M

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Gene Security Network has closed a $6 million Series B round of financing, the Redwood City, Calif.-based firm said today.
 
The company is developing its Parental Support technology, which uses data informatics to deliver single-cell testing for chromosome abnormalities and genetic diseases. GSN also operates a CLIA-certified lab in California, providing testing services to help guide physicians in selecting embryos during in vitro fertilization.
 
“Our technology will enable a host of services that make genetic information actionable, so that doctors worldwide can order tests to improve the quality of life for their patients,” GSN President and CEO Matthew Rabinowitz said in a statement.
 
The firm’s existing investors, Claremont Creek Ventures and Sequoia Capital, participated in the round of financing along with new investor Alafi Capital.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.